Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.

Roger LiParas H ShahTyler F StewartJong Kil NamTrinity J BivalacquaDonald L LammEdward M UchioDaniel M GeynismanJoseph M JacobJoshua J MeeksRian DicksteinShane M PearceSeok Ho KangSeung Il JungAshish M KamatJames M BurkeKirk A KeeganGary D Steinberg

Published in: Nature medicine (2024)

Keyphrases

muscle invasive bladder cancer
study protocol
phase iii
clinical trial
advanced non small cell lung cancer
phase ii
randomized controlled trial
stem cells
cell therapy
replacement therapy